Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_L04AX
Extra metadata
List of similar endpoints to
L04AX Other immunosuppressants
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13162 | 8195 | 4967 |
| Unadjusted prevalence (%) | 5.06 | 5.58 | 4.39 |
| Mean age at first event (years) | 51.09 | 50.38 | 52.28 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.04 | 2.70 [2.21, 3.29] | 1.2e-22 | 651 |
| 15 years | 0.02 | 2.80 [2.29, 3.42] | 1.2e-23 | 610 |
| 5 years | 0.00 | 3.79 [3.08, 4.66] | 4.1e-36 | 247 |
| 1 year | 0.00 | 3.00 [2.09, 4.32] | 2.8e-9 | 38 |
Index endpoint: RX_L04AX – L04AX Other immunosuppressants
GWS hits:
before L04AX Other immunosuppressants
after L04AX Other immunosuppressants
Loading survival analyses plot
Loading survival analyses table